Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§

Movement Disorders : Official Journal of the Movement Disorder Society
Juliane WinkelmannCristina Sampaio

Abstract

The objective of the current review was to update the previous evidence-based medicine review of treatments for restless legs syndrome published in 2008. All randomized, controlled trials (level I) with a high quality score published between January 2007 and January 2017 were reviewed. Forty new studies qualified for efficacy review. Pregabalin, gabapentin enacarbil, and oxycodone/naloxone, which did not appear in the previous review, have accrued data to be considered efficacious. Likewise, new data enable the modification of the level of efficacy for rotigotine from likely efficacious to efficacious. Intravenous ferric carboxymaltose and pneumatic compression devices are considered likely efficacious in idiopathic restless legs syndrome. Bupropion and clonidine were reviewed, but the lack of data determined a rating of insufficient evidence for efficacy. The following interventions continue to be considered efficacious as in 2008: levodopa, ropinirole, pramipexole, cabergoline, pergolide, and gabapentin. Bromocriptine, oxycodone, carbamazepine, and valproic acid are considered likely efficacious. Oral iron is nonefficacious in iron-sufficient subjects, but its benefit for patients with low peripheral iron status has not been ...Continue Reading

References

Nov 12, 1994·BMJ : British Medical Journal·K DickersinC Lefebvre
Jan 1, 1995·Journal of Clinical Epidemiology·G GrégoireJ Le Lorier
May 1, 1994·Age and Ageing·S T O'KeeffeJ N Lavan
Apr 2, 1999·Neurology·J MontplaisirB Gomez-Mancilla
Jun 30, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M L ThorpS P Bagby
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·A S WaltersL Li
Sep 25, 2003·Neuropsychobiology·Svenja HappeJosef Zeitlhofer
Mar 26, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·James A SloandRebeca D Monk
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Arthur S WaltersKapil Sethi
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Karin Stiasny-KolsterUNKNOWN Rotigotine Sp 666 Study Group
Dec 30, 2004·Neurology·K Stiasny-KolsterW H Oertel
Jun 7, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderJuergen Reess
Aug 26, 2006·Neurology·J W WinkelmanJ Reess
Sep 5, 2006·Journal of the American Board of Family Medicine : JABFM·Melissa McManama AukermanBeth Bailey
Nov 30, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Wolfgang H OertelUNKNOWN Pramipexole RLS Study Group
Feb 3, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderUNKNOWN CALDIR Study Group
Oct 18, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderCristina Sampaio
Jun 3, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Ludger GroteJan Ulfberg
Aug 12, 2009·Clinical Neuropharmacology·Arthur S WaltersUNKNOWN XP045 Study Group
Jun 1, 2010·Mayo Clinic Proceedings·Richard K BoganUNKNOWN XP060 Study Group
Jul 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Wayne A HeningUNKNOWN SP792 Study Group

❮ Previous
Next ❯

Citations

Feb 3, 2019·Acta Neurologica Scandinavica·Margrete Larsen BurnsCecilie Johannessen Landmark
Jun 4, 2019·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Chien-Wei HuangPao-Yen Lin
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Aaro V SalminenJuliane Winkelmann
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Aaro V SalminenJuliane Winkelmann
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Jesus CalviñoMaria-Jesus Sobrido
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Howard D Weiss
Jun 25, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ambra Stefani, Birgit Högl
Jul 11, 2019·Expert Opinion on Pharmacotherapy·Wolfgang H Jost, Carsten Buhmann
Jul 31, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Aaro V SalminenJuliane Winkelmann
Sep 16, 2020·Der Nervenarzt·Michael BartlFrie de Ri Ke Sixel-Döring
Aug 11, 2018·Expert Review of Neurotherapeutics·Marco ZucconiLuigi Ferini-Strambi
Aug 24, 2019·JAMA Network Open·Sheng ZhuangXiang Gao
Nov 11, 2019·Current Treatment Options in Neurology·Valérie Cochen De Cock
May 28, 2020·International Journal of Environmental Research and Public Health·Giuseppe DidatoPaola Lanteri
Jun 23, 2020·Journal of Parkinson's Disease·Carsten BuhmannWolfgang H Jost
Sep 8, 2020·Expert Opinion on Drug Safety·Laura OrsoliniUmberto Volpe
Nov 10, 2018·Current Treatment Options in Neurology·Aaro V Salminen, Juliane Winkelmann
Jun 30, 2019·Current Neurology and Neuroscience Reports·Paulina Gonzalez-Latapi, Roneil Malkani
Jul 29, 2019·Current Neurology and Neuroscience Reports·Semiha Kurt
Sep 9, 2020·MMW Fortschritte der Medizin·Jan Rémi
Oct 3, 2019·Expert Review of Neurotherapeutics·Matthew J BarrettKathryn L Holloway
Oct 9, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·José Rafael P Zuzuárregui, Emmanuel H During
Oct 29, 2020·Arquivos de neuro-psiquiatria·Adalet ArikanogluMehmet Ufuk Aluclu
Nov 27, 2020·Communications Biology·Maria DidriksenKari Stefansson
Jan 1, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Aaro V SalminenUNKNOWN International Restless Legs Syndrome Study Group (IRLSSG)
Sep 22, 2020·Chest·Annie C LajoieMarta Kaminska
Jul 19, 2020·La Revue de médecine interne·M AubignatP Krystkowiak
Nov 12, 2019·Deutsches Ärzteblatt International·Jan RémiPeter Young
Sep 28, 2020·Neurología : publicación oficial de la Sociedad Española de Neurología·R García-RamosP Mir
Nov 20, 2020·ESMO Open·D SantiniUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Dec 4, 2019·Journal of Psychosomatic Research·Phillip J TullyChristophe Tzourio
Apr 22, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Thomas R GossardErik K St Louis
May 15, 2021·Sleep Medicine Clinics·Laura M Botta PDiego Garcia-Borreguero
May 15, 2021·Sleep Medicine Clinics·Ambra Stefani, Birgit Högl
May 26, 2021·Journal of Primary Care & Community Health·Audrey UmbreitMeghna P Mansukhani
May 1, 2021·Journal of Movement Disorders·Joohwan KimSung Hee Hwang
Jun 19, 2021·Fortschritte der Neurologie-Psychiatrie·Moritz D Brandt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.